Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021GlobeNewsWire • 03/03/21
Pacira BioSciences to Present at the 2021 Barclays Global Healthcare ConferenceGlobeNewsWire • 03/03/21
Flexion Therapeutics To Start Testing FX301 For Post-Op Pain In Patients After Musculoskeletal SurgeryBenzinga • 03/01/21
Flexion Therapeutics Announces FDA Clearance of Investigational New Drug Application for FX301, a Novel Formulation of a Locally Administered NaV1.7 Inhibitor for Post-Operative PainGlobeNewsWire • 03/01/21
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial ResultsGlobeNewsWire • 02/25/21
Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors ConferenceGlobeNewsWire • 02/22/21
Flexion To Test Higher Dose Of FX201 Gene Therapy In Early-Stage Osteoarthritis StudyBenzinga • 02/18/21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021GlobeNewsWire • 02/10/21
National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®GlobeNewsWire • 02/01/21
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 ResultsGlobeNewsWire • 01/13/21
Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/21
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020GlobeNewsWire • 12/09/20
Flexion Therapeutics to Present at the Needham Virtual Epilepsy and Pain Specialty CNS Therapeutics ConferenceGlobeNewsWire • 12/07/20
Pacira BioSciences to Present at the 2020 Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20